Back
Entrada Therapeutics Vs. Affirm Holdings Industry Stock Comparison
Buy
79
TRDA
Entrada Therapeutics
Last Price:
19.97
Seasonality Move:
-35.78%
Buy
53
AFRM
Affirm Holdings
Last Price:
54.82
Seasonality Move:
1.82%
Buy
79
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $19.79. The Score for TRDA is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Affirm Holdings (AFRM)
is a Buy
Is Affirm Holdings a Buy, Sell or Hold?
- The current Affirm Holdings [AFRM] share price is $57.56. The Score for AFRM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AFRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $19.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
AFRM Stock Price Chart
What is Affirm Holdings's stock price today?
-
The Affirm Holdings share price today is $57.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AFRM is experiencing buying pressure, which is a positive indicator for future bullish movement.
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 75.02 | Buy |
| Chaikin Money Flow: | 113940 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.57 - 18.73) | Buy |
| Bollinger Bands (100): | (14.77 - 17.59) | Buy |
AFRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 71.38 | Buy |
| Chaikin Money Flow: | 13820195 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.35 - 50.03) | Buy |
| Bollinger Bands (100): | (28.43 - 44.53) | Buy |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.92 | Buy |
| 20-day SMA: | 17.91 | Buy |
| 50-day SMA: | 16.49 | Buy |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 19.05 | Buy |
| 20-day EMA: | 18.11 | Buy |
| 50-day EMA: | 17.08 | Buy |
| 200-day EMA: | 15.67 | Buy |
AFRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.12 | Buy |
| 20-day SMA: | 45.98 | Buy |
| 50-day SMA: | 43.52 | Buy |
| 200-day SMA: | 35.74 | Buy |
| 8-day EMA: | 50.67 | Buy |
| 20-day EMA: | 47.02 | Buy |
| 50-day EMA: | 43.01 | Buy |
| 200-day EMA: | 35.89 | Buy |
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.
Affirm Holdings Earnings Growth & AFRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $1.43 per share.
Entrada Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affirm Holdings Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||